Genmab — Februar 2024
-
10 stocks with huge cash position vs capitalisation https://twitter.com/aifininsights/status/1762538260805329352
-
Zai Lab to submit an NDA to the NMPA in second-line+ cervical cancer. https://www.businesswire.com/news/home/20240227802106/en/Zai-Lab-Announces-Full-Year-2023-Financial-Results-and-Recent-Corporate-Updates
-
Capital Increase in Genmab as a Result of Employee Warrant Exercise https://www.proinvestor.com/investornyt/1124046/capital-increase-in-genmab-as-a-result-of-employee-warrant-exercise
-
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons https://www.proinvestor.com/investornyt/1124047/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons
-
...except the organization is putting on wheight at an alarming rate
-
Karakterbogen er landet - Så er det tid til at give karakterer til nogle af de største danske selskaber. Hør blandt andet om Mærsk, ISS, Novo Nordisk, Vestas, Genmab, Rockwool, Carlsberg, Bavarian Nordic og til sidst sluttes der af med en gennemgang af Zealand Pharma https://www.proinvestor.com/boards/119016
-
Victory for patients with incurable disease after NHS treatment U-turn [ Daratumumab in combination for treating
newly diagnosed systemic amyloid light-chain
amyloidosis ] https://inews.co.uk/news/health/al-amyloidosis-treatment-u-turn-nice-nhs-2929429 -
any chance GEN is going short on the stock purchase program?
-
.-D
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind